Patricia Fierro, David Martín, Emilio Pariente-Rodrigo, Stefanie F Pini, Héctor Basterrechea, Marian Tobalina, Benedetta Petitta, Camila Bianconi, Sara Díaz-Salazar, Merelyn Bonome, Carmen Ramos-Barrón, José L Hernández-Hernández
BACKGROUND: COVID-19-induced diabetes is a novel and enigmatic disease. Our aim was to evaluate a possible relationship between post-COVID-19 syndrome (PCS) and increased insulin resistance (IR) in non-diabetic outpatients after mild COVID-19. METHODS: Repeated measures design. Three evaluations [1E (pre-COVID, baseline), 2E (3 months post-COVID) and 3E (21 months post-COVID)] were performed, directed to PCS+ and PCS- subjects. Triglyceride-glucose (TyG) index ≥8...
April 24, 2024: Minerva endocrinology